Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter

Molecular and Cellular Biology

Volumn 31, Issue 16, 2011, Pages 3339-3350

  Lu, Yuhong ^a   Chu, Adrian ^b   Turker, Mitchell S ^b   Glazer, Peter M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; HISTONE DEACETYLASE INHIBITOR; HISTONE DEMETHYLASE; HISTONE H3; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LYSINE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); RAD51 PROTEIN; VASCULOTROPIN;

ARTICLE; CLONE; DOWN REGULATION; EPIGENETICS; GENE SILENCING; GENOMIC INSTABILITY; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR GROWTH;

ANOXIA; CELL LINE, TUMOR; EPIGENESIS, GENETIC; GENE SILENCING; GENES, BRCA1; GENES, TUMOR SUPPRESSOR; GENOMIC INSTABILITY; HISTONE DEACETYLASES; HISTONES; HUMANS; METHYLATION; PROMOTER REGIONS, GENETIC;

EID: 79961131128     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01121-10     Document Type: Article

References (58)

1. Banelli, B., I. Casciano, and M. Romani. 2000. Methylation-independent silencing of the p73 gene in neuroblastoma. Oncogene 19:4553-4556.
2. Beyer, S., M. M. Kristensen, K. S. Jensen, J. V. Johansen, and P. Staller. 2008. The histone demethylases JMJD1A and JMJD2B are transcriptional targets of hypoxia-inducible factor HIF. J. Biol. Chem. 283:36542-36552.
3. Bindra, R. S., et al. 2005. Hypoxia-induced down-regulation of BRCA1 expression by E2Fs. Cancer Res. 65:11597-11604.
4. Bindra, R. S., and P. M. Glazer. 2007. Co-repression of mismatch repair gene expression by hypoxia in cancer cells: role of the Myc/Max network. Cancer Lett. 252:93-103.
5. Bindra, R. S., and P. M. Glazer. 2005. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat. Res. 569:75-85.
6. Bindra, R. S., and P. M. Glazer. 2007. Repression of RAD51 gene expression by E2F4//p130 complexes in hypoxia. Oncogene 26:2048-2057.
7. Bindra, R. S., et al. 2004. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol. Cell. Biol. 24:8504-8518.
8. Catteau, A., W. H. Harris, C. F. Xu, and E. Solomon. 1999. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:1957-1965.
9. Chen, H., Y. Yan, T. L. Davidson, Y. Shinkai, and M. Costa. 2006. Hypoxic stress induces dimethylated histone H3 lysine 9 through histone methyltransferase G9a in mammalian cells. Cancer Res. 66:9009-9016.
10. Cloos, P. A., J. Christensen, K. Agger, and K. Helin. 2008. Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22:1115-1140.
11. Coquelle, A., E. Pipiras, F. Toledo, G. Buttin, and M. Debatisse. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
12. Coquelle, A., F. Toledo, S. Stern, A. Bieth, and M. Debatisse. 1998. A new role for hypoxia in tumor progression: induction of fragile site triggering genomic rearrangements and formation of complex DMs and HSRs. Mol. Cell 2:259-265.
13. Ebert, A., S. Lein, G. Schotta, and G. Reuter. 2006. Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosome Res. 14:377-392.
14. Esteller, M., P. G. Corn, S. B. Baylin, and J. G. Herman. 2001. A gene hypermethylation profile of human cancer. Cancer Res. 61:3225-3229.
15. Hegan, D. C., et al. 2010. Inhibition of poly(ADP-ribose) polymerase downregulates BRCA1 and RAD51 in a pathway mediated by E2F4 and p130. Proc. Natl. Acad. Sci. U. S. A. 107:2201-2206.
16. Herman, J. G., et al. 1998. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 95:6870-6875.
17. Hublitz, P., M. Albert, and A. H. Peters. 2009. Mechanisms of transcriptional repression by histone lysine methylation. Int. J. Dev. Biol. 53:335-354.
18. Jackson, J. P., A. M. Lindroth, X. Cao, and S. E. Jacobsen. 2002. Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase. Nature 416:556-560.
19. Jin, W., et al. 2010. UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer. Breast Cancer Res. Treat. 123:359-373.
20. Johnson, A. B., N. Denko, and M. C. Barton. 2008. Hypoxia induces a novel signature of chromatin modifications and global repression of transcription. Mutat. Res. 640:174-179.
21. Karray-Chouayekh, S., et al. 2009. Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma. J. Biomed. Biotechnol. 2009:369129.
22. Kasper, L. H., et al. 2005. Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. EMBO J. 24:3846-3858.
23. Kim, J. K., M. Samaranayake, and S. Pradhan. 2009. Epigenetic mechanisms in mammals. Cell. Mol. Life Sci. 66:596-612.
24. Klose, R. J., et al. 2007. The retinoblastoma binding protein RBP2 is an H3K4 demethylase. Cell 128:889-900.
25. Klose, R. J., and Y. Zhang. 2007. Regulation of histone methylation by demethylimination and demethylation. Nat. Rev. Mol. Cell Biol. 8:307-318.
26. Kondo, Y., et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat. Genet. 40: 741-750.
27. Krieg, A. J., et al. 2010. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1 alpha enhances hypoxic gene expression and tumor growth. Mol. Cell. Biol. 30:344-353.
28. Krishnan, S., S. Horowitz, and R. C. Trievel. 2011. Structure and function of histone H3 lysine 9 methyltransferases and demethylases. Chembiochem 12:254-263.
29. Lee, S. H., J. Kim, W. H. Kim, and Y. M. Lee. 2009. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28:184-194.
30. Li, X., J. Liu, R. Zhou, S. Huang, and X. M. Chen. 2010. Gene silencing ofMIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation. Br. J. Haematol. 148:69-79.
31. Litt, M. D., M. Simpson, M. Gaszner, C. D. Allis, and G. Felsenfeld. 2001. Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus. Science 293:2453-2455.
32. Maison, C., et al. 2002. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat. Genet. 30:329-334.
33. McGarvey, K. M., et al. 2006. Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state. Cancer Res. 66:3541-3549.
34. Mihaylova, V. T., et al. 2003. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell. Biol. 23:3265-3273.
35. Mirza, S., et al. 2007. Promoter hypermethylation of TMS1, BRCA1, ERα and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Life Sci. 81:280-287.
36. Nakayama, J.-i., J. C. Rice, B. D. Strahl, C. D. Allis, and S. I. S. Grewal. 2001. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292:110-113.
37. Ooi, S. K. T., et al. 2007. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448:714-717.
38. Oyer, J. A., A. Chu, S. Brar, and M. S. Turker. 2009. Aberrant epigenetic silencing is triggered by a transient reduction in gene expression. PLoS One 4:e4832.
39. Peters, A. H. F. M., et al. 2002. Histone H3 lysine 9 methylation is an epigenetic imprint of facultative heterochromatin. Nat. Genet. 30:77-80.
40. Reynolds, T. Y., S. Rockwell, and P. M. Glazer. 1996. Genetic instability induced by the tumor microenvironment. Cancer Res. 56:5754-5757.
41. Shi, Y. 2007. Histone lysine demethylases: emerging roles in development, physiology and disease. Nat. Rev. Genet. 8:829-833.
42. Shi, Y., et al. 2004. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941-953.
43. Shi, Y., and J. R. Whetstine. 2007. Dynamic regulation of histone lysine methylation by demethylases. Mol. Cell 25:1-14.
44. Sonoda, E., et al. 1998. Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J. 17:598-608.
45. Stirzaker, C., J. Z. Song, B. Davidson, and S. J. Clark. 2004. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res. 64:3871-3877.
46. Tamaru, H., et al. 2003. Trimethylated lysine 9 of histone H3 is a mark for DNA methylation in Neurospora crassa. Nat. Genet. 34:75-79.
47. Turker, M. S., P. Mummaneni, and P. L. Bishop. 1991. Region- and cell type-specific de novo DNA methylation in cultured mammalian cells. Somat. Cell Mol. Genet. 17:151-157.
48. Vakoc, C. R., M. M. Sachdeva, H. Wang, and G. A. Blobel. 2006. Profile of histone lysine methylation across transcribed mammalian chromatin. Mol. Cell. Biol. 26:9185-9195.
49. van Zeeland, A. A., and J. U. Simons. 1976. The use of correction factors in the determination of mutant frequencies in populations of human diploid skin fibroblasts. Mutat. Res. 34:149-158.
50. Vasilatos, S. N., et al. 2009. CpG island tumor suppressor promoter methylation in non-BRCA-associated early mammary carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 18:901-914.
51. Wei, M., et al. 2005. BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res. 65:10692-10699.
52. Wei, M., et al. 2008. Estrogen receptor alpha, BRCA1, and FANCF promoter methylation occur in distinct subsets of sporadic breast cancers. Breast Cancer Res. Treat. 111:113-120.
53. Xia, X., et al. 2009. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc. Natl. Acad. Sci. U. S. A. 106:4260-4265.
54. Xiong, Y., S. C. Dowdy, N. L. Eberhardt, K. C. Podratz, and S.-W. Jiang. 2006. hMLH1 promoter methylation and silencing in primary endometrial cancers are associated with specific alterations in MBDs occupancy and histone modifications. Gynecol. Oncol. 103:321-328.
55. Yamane, K., et al. 2007. PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. Mol. Cell 25:801-812.
56. Yang, J., et al. 2009. Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann. N. Y. Acad. Sci. 1177:185-197.
57. Yang, X. J., and E. Seto. 2007. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310-5318.
58. Young, S. D., R. S. Marshall, and R. P. Hill. 1988. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. U. S. A. 85:9533-9537.